PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.35 +0.01 (+1.86%)
As of: Oct 22, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Debt Ratio (2011 - 2021)

Updated

PharmaCyte Biotech's (PMCB) Debt Ratio stood at 0.02 in fiscal Q3 2021 (quarter ended Jan 31, 2021), up 18.8% from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Debt Ratio (2011 - 2021) Analysis & Trends

For FY2020 (ended Apr 30, 2020), PharmaCyte Biotech's Debt Ratio came in at 0.01.

  • The fiscal Q3 2021 figure is the highest quarterly Debt Ratio since fiscal Q2 2014.
  • Per Business Quant, the preceding three fiscal quarters came in at 0.01 (Q2 2021), 0.02 (Q1 2021) and 0.01 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 0.39
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.23
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 0.52
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 0.42
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 0.08
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 0.28
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 0.53
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 0.31
10 PharmaCyte Biotech 3.79 Mn -69.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2021 0.02
Oct 31, 2020 0.01
Jul 31, 2020 0.02
Apr 30, 2020 0.01
Jan 31, 2014 0.00
Oct 31, 2013 0.09
Jul 31, 2013 0.12
Apr 30, 2013 0.15
Jan 31, 2013 0.17
Oct 31, 2012 0.18
Jul 31, 2012 0.33
Apr 30, 2012 1.00
Jan 31, 2012 1.32
Oct 31, 2011 1.37
Jul 31, 2011 1.50
Apr 30, 2011 1.91
API Access

PharmaCyte Biotech Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=PMCB&period=max&api_key=YOUR_API_KEY